WGS (genedx.com) Penghasilan resik perusahaan

GeneDx Holdings Corp. (WGS) net income on this GURU.Markets chart reflects a trend where the -0.10 indicator expresses the metric level. Growth is driven by Big Data monetization through the licensing of mutation databases. Stability is supported by logistics optimization and cloud computing, while operational risks are mitigated by a shift toward high-margin genome sequencing, which offsets pressure from insurance companies.

WGS - Penghasilan resik genedx.com ing rentang 28.04.2023 - 01.11.2026

Rincian metrik keuangan lan pasar GeneDx (WGS)

- kuotasi lan prakiraan analis:

Kurs saham GeneDx Corp|WGS - Prakiraan konsensus analis

- indikator valuasi pasar bisnis:

Nilai pasar GeneDx Corp|WGS - Nilai Perusahaan

- data ekuitas miturut neraca:

Ekuitas saben Saham GeneDx|WGS - Aset Bersih Perusahaan|Rasio Kapitalisasi marang Nilai Buku genedx.com|WGS - Gunggung Aset Perusahaan

- indikator beban utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi GeneDx Holdings Corp.|WGS - Utang jangka dawa marang modal|Rasio tanggungan utang jangka cendhak marang modal GeneDx Holdings|WGS - Utang perusahaan|Utang-utang marang nilai buku GeneDx Corp|WGS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan GeneDx|Rasio likuiditas darurat genedx.com

- statistik bathi lan rasio pasar:

WGS - Bathi resik

Analisis dhasar perusahaan:WGS GeneDx Corp

Amid aggressive dumping in the genetic analysis sector, GeneDx Holdings Corp. faces the risk of margin erosion due to the competition for hospital contracts. The dynamics of the company's excess income reflect management's actual ability to generate net cash flow after covering all operating expenses, allowing investors to assess the business's resilience to price wars through the stability of this curve.

Pesaing utama